An international symposium at Jiahui International Hospital in Shanghai showcased the success of CAR-T therapy in treating hematologic malignancies. Experts from numerous countries, including Russia's Borzenkov who achieved complete remission, discussed the groundbreaking treatment, its global accessibility, and the partnerships facilitating international patient care.